Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Negoro, Hiromitsu ^a   Lutz, Sarah E ^a   Liou, Louis S ^b   Kanematsu, Akihiro ^c,d   Ogawa, Osamu ^c   Scemes, Eliana ^a   Suadicani, Sylvia O ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Cambridge Health Alliance ^*  (United States)

^c KYOTO UNIVERSITY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; GAP JUNCTION PROTEIN; INTERLEUKIN 1BETA; NERVE PROTEIN; PANX1 PROTEIN, MOUSE; PROTEIN KINASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL; ARTICLE; BLADDER; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CONNEXIN 43; CONNEXINS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-1BETA; MICE; MULTIPLE SCLEROSIS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN KINASES; SIGNAL TRANSDUCTION; URINARY BLADDER;

EID: 84881366962     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02152     Document Type: Article

References (95)

1. McCombe, P. A., Gordon, T. P. & Jackson, M. W. Bladder dysfunction in multiple sclerosis. Expert Rev. Neurother. 9, 331-340 (2009).
2. de Seze, M., Ruffion, A., Denys, P., Joseph, P. A. & Perrouin-Verbe, B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult. Scler. 13, 915-928 (2007). (Pubitemid 351540864)
3. Lassmann, H. Models of multiple sclerosis: new insights into pathophysiology and repair. Curr. Opin. Neurol. 21, 242-247 (2008). (Pubitemid 351653971)
4. Constantinescu, C. S., Farooqi, N., O'Brien, K. & Gran, B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164, 1079-1106 (2011).
5. Al-Izki, S., Pryce, G., Giovannoni, G. & Baker, D. Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with highresolution ultrasonography. Mult. Scler. 15, 795-801 (2009).
6. Altuntas, C. Z. et al. Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 203, 58-63 (2008).
7. Altuntas, C. Z. et al. Connective tissue and its growth factor CTGF distinguish the morphometric and molecular remodeling of the bladder in amodel of neurogenic bladder. Am. J. Physiol. Renal Physiol. 303, F1363-F1369 (2012).
8. Vignes, J. R., Deloire, M. S., Petry, K. G. & Nagy, F. Characterization and restoration of altered inhibitory and excitatory control of micturition reflex in experimental autoimmune encephalomyelitis in rats. J. Physiol. 578, 439-450 (2007). (Pubitemid 46092208)
9. Mizusawa, H. et al.Arat model for investigation of bladder dysfunction associated with demyelinating disease resembling multiple sclerosis. Neurourol. Urodyn. 19, 689-699 (2000).
10. Ciancio, S. J., Mutchnik, S. E., Rivera, V. M. & Boone, T. B. Urodynamic pattern changes in multiple sclerosis. Urology 57, 239-245 (2001). (Pubitemid 32140796)
11. Andersson, K. E. & Arner, A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84, 935-986 (2004). (Pubitemid 38823771)
12. Birder, L. A. & de Groat, W. C. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat. Clin. Pract. Urol. 4, 46-54 (2007). (Pubitemid 46062986)
13. Davidoff, R., Yamaguchi, R., Leach, G. E., Park, E. & Lad, P. M. Multiple urinary cytokine levels of bacterial cystitis. J. Urol. 157, 1980-1985 (1997). (Pubitemid 27171824)
14. Imamura, M. et al. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. Am. J. Physiol. Renal Physiol. 293, F1007-F1017 (2007). (Pubitemid 47583932)
15. Dozmorov, M. G. et al. Systems biology approach for mapping the response of human urothelial cells to infection by Enterococcus faecalis. BMC Bioinformatics 8 Suppl 7, S2 (2007).
16. Wognum, S., Lagoa, C. E., Nagatomi, J., Sacks, M. S. & Vodovotz, Y. An exploratory pathways analysis of temporal changes induced by spinal cord injury in the rat bladder wall: insights on remodeling and inflammation. PLoS One 4, e5852 (2009).
17. Imamura, M. et al. Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle. Am. J. Physiol. Renal Physiol. 297, F46-F54 (2009).
18. Negoro, H. et al. Regulation of connexin 43 by basic fibroblast growth factor in the bladder: transcriptional and behavioral implications. J. Urol. 185, 2398-2404 (2011).
19. Birder, L. A. Nervous network for lower urinary tract function. Int. J. Urol. 20, 4-12 (2013).
20. Roosen, A. et al.Arefocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur. Urol. 56, 810-819 (2009).
21. Ford, A. P. & Cockayne, D. A. ATP and P2X purinoceptors in urinary tract disorders. Handb. Exp. Pharmacol. 202, 485-526 (2011).
22. Nile, C. J. & Gillespie, J. I. Interactions between cholinergic and prostaglandin signaling elements in the urothelium: role for muscarinic type 2 receptors. Urology 79, 240.e17-240.e23 (2012).
23. Skryma, R., Prevarskaya, N., Gkika, D. & Shuba, Y. From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat. Rev. Urol. 8, 617-630 (2011).
24. Fry, C. H., Sui, G. P., Kanai, A. J. & Wu, C. The function of suburothelial myofibroblasts in the bladder. Neurourol. Urodyn. 26, 914-919 (2007). (Pubitemid 47548228)
25. Scemes, E., Spray, D. C. & Meda, P. Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch. 457, 1207-1226 (2009).
26. Silverman, W. R. et al. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem. 284, 18143-18151 (2009).
27. Gulbransen, B. D. et al. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 18, 600-604 (2012).
28. Thi, M. M., Islam, S., Suadicani, S. O. & Spray, D. C. Connexin43 and pannexin1 channels in osteoblasts: who is the "hemichannel"? J. Membr. Biol. 245, 401-409 (2012).
29. Negoro, H. et al. Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm. Nat. Commun. 3, 809 (2012).
30. Negoro, H. et al. Development of diurnal micturition pattern in mice after weaning. J. Urol. 189, 740-746 (2013).
31. Kim, J. E. & Kang, T. C. The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J. Clin. Invest. 121, 2037-2047 (2011).
32. Csak, T. et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133-144 (2011).
33. Suadicani, S. O., Urban-Maldonado, M., Tar, M. T., Melman, A. & Spray, D. C. Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int. 103, 1686-1693 (2009).
34. Pelegrin, P. & Surprenant, A. Pannexin-1 couples to maitotoxin- and nigericininduced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem. 282, 2386-2394 (2007). (Pubitemid 47076789)
35. Li, K. et al. Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J. Biol. Chem. 286, 41552-41562 (2011).
36. Tonon, R. & D'Andrea, P. Interleukin-1beta increases the functional expression of connexin 43 in articular chondrocytes: evidence for a Ca21-dependent mechanism. J. Bone Miner. Res. 15, 1669-1677 (2000). (Pubitemid 30666221)
37. Kim, J. et al. An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor. In Vitro Cell Dev. Biol. Anim. 47, 2-9 (2011).
38. McCombe, P. A., Gordon, T. P. & Jackson, M. W. Bladder dysfunction in multiple sclerosis. Expert Rev. Neurother. 9, 331-340 (2009).
39. de Seze, M., Ruffion, A., Denys, P., Joseph, P. A. & Perrouin-Verbe, B. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult. Scler. 13, 915-928 (2007). (Pubitemid 351540864)
40. Lassmann, H. Models of multiple sclerosis: new insights into pathophysiology and repair. Curr. Opin. Neurol. 21, 242-247 (2008). (Pubitemid 351653971)
41. Constantinescu, C. S., Farooqi, N., O'Brien, K. & Gran, B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164, 1079-1106 (2011).
42. Al-Izki, S., Pryce, G., Giovannoni, G. & Baker, D. Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with highresolution ultrasonography. Mult. Scler. 15, 795-801 (2009).
43. Altuntas, C. Z. et al. Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 203, 58-63 (2008).
44. Altuntas, C. Z. et al. Connective tissue and its growth factor CTGF distinguish the morphometric and molecular remodeling of the bladder in amodel of neurogenic bladder. Am. J. Physiol. Renal Physiol. 303, F1363-F1369 (2012).
45. Vignes, J. R., Deloire, M. S., Petry, K. G. & Nagy, F. Characterization and restoration of altered inhibitory and excitatory control of micturition reflex in experimental autoimmune encephalomyelitis in rats. J. Physiol. 578, 439-450 (2007). (Pubitemid 46092208)
46. Mizusawa, H. et al.Arat model for investigation of bladder dysfunction associated with demyelinating disease resembling multiple sclerosis. Neurourol. Urodyn. 19, 689-699 (2000).
47. Ciancio, S. J., Mutchnik, S. E., Rivera, V. M. & Boone, T. B. Urodynamic pattern changes in multiple sclerosis. Urology 57, 239-245 (2001). (Pubitemid 32140796)
48. Andersson, K. E. & Arner, A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 84, 935-986 (2004). (Pubitemid 38823771)
49. Birder, L. A. & de Groat, W. C. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nat. Clin. Pract. Urol. 4, 46-54 (2007). (Pubitemid 46062986)
50. Davidoff, R., Yamaguchi, R., Leach, G. E., Park, E. & Lad, P. M. Multiple urinary cytokine levels of bacterial cystitis. J. Urol. 157, 1980-1985 (1997). (Pubitemid 27171824)
51. Imamura, M. et al. Basic fibroblast growth factor modulates proliferation and collagen expression in urinary bladder smooth muscle cells. Am. J. Physiol. Renal Physiol. 293, F1007-F1017 (2007). (Pubitemid 47583932)
52. Dozmorov, M. G. et al. Systems biology approach for mapping the response of human urothelial cells to infection by Enterococcus faecalis. BMC Bioinformatics 8 Suppl 7, S2 (2007).
53. Wognum, S., Lagoa, C. E., Nagatomi, J., Sacks, M. S. & Vodovotz, Y. An exploratory pathways analysis of temporal changes induced by spinal cord injury in the rat bladder wall: insights on remodeling and inflammation. PLoS One 4, e5852 (2009).
54. Imamura, M. et al. Basic fibroblast growth factor causes urinary bladder overactivity through gap junction generation in the smooth muscle. Am. J. Physiol. Renal Physiol. 297, F46-F54 (2009).
55. Negoro, H. et al. Regulation of connexin 43 by basic fibroblast growth factor in the bladder: transcriptional and behavioral implications. J. Urol. 185, 2398-2404 (2011).
56. Birder, L. A. Nervous network for lower urinary tract function. Int. J. Urol. 20, 4-12 (2013).
57. Roosen, A. et al.Arefocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur. Urol. 56, 810-819 (2009).
58. Ford, A. P. & Cockayne, D. A. ATP and P2X purinoceptors in urinary tract disorders. Handb. Exp. Pharmacol. 202, 485-526 (2011).
59. Nile, C. J. & Gillespie, J. I. Interactions between cholinergic and prostaglandin signaling elements in the urothelium: role for muscarinic type 2 receptors. Urology 79, 240.e17-240.e23 (2012).
60. Skryma, R., Prevarskaya, N., Gkika, D. & Shuba, Y. From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat. Rev. Urol. 8, 617-630 (2011).
61. Fry, C. H., Sui, G. P., Kanai, A. J. & Wu, C. The function of suburothelial myofibroblasts in the bladder. Neurourol. Urodyn. 26, 914-919 (2007). (Pubitemid 47548228)
62. Scemes, E., Spray, D. C. & Meda, P. Connexins, pannexins, innexins: novel roles of "hemi-channels". Pflugers Arch. 457, 1207-1226 (2009).
63. Silverman, W. R. et al. The pannexin 1 channel activates the inflammasome in neurons and astrocytes. J. Biol. Chem. 284, 18143-18151 (2009).
64. Gulbransen, B. D. et al. Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat. Med. 18, 600-604 (2012).
65. Thi, M. M., Islam, S., Suadicani, S. O. & Spray, D. C. Connexin43 and pannexin1 channels in osteoblasts: who is the "hemichannel"? J. Membr. Biol. 245, 401-409 (2012).
66. Negoro, H. et al. Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm. Nat. Commun. 3, 809 (2012).
67. Negoro, H. et al. Development of diurnal micturition pattern in mice after weaning. J. Urol. 189, 740-746 (2013).
68. Kim, J. E. & Kang, T. C. The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J. Clin. Invest. 121, 2037-2047 (2011).
69. Csak, T. et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54, 133-144 (2011).
70. Suadicani, S. O., Urban-Maldonado, M., Tar, M. T., Melman, A. & Spray, D. C. Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int. 103, 1686-1693 (2009).
71. Pelegrin, P. & Surprenant, A. Pannexin-1 couples to maitotoxin- and nigericininduced interleukin-1beta release through a dye uptake-independent pathway. J. Biol. Chem. 282, 2386-2394 (2007). (Pubitemid 47076789)
72. Li, K. et al. Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J. Biol. Chem. 286, 41552-41562 (2011).
73. Tonon, R. & D'Andrea, P. Interleukin-1beta increases the functional expression of connexin 43 in articular chondrocytes: evidence for a Ca21-dependent mechanism. J. Bone Miner. Res. 15, 1669-1677 (2000). (Pubitemid 30666221)
74. Kim, J. et al. An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor. In Vitro Cell Dev. Biol. Anim. 47, 2-9 (2011).
75. Larsen, C. M. et al. Interleukin-1beta-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Biol. Chem. 273, 15294-15300 (1998). (Pubitemid 28272832)
76. Bellei, B. et al. Ultraviolet A induced modulation of gap junctional intercellular communication by P38MAPKactivation in human keratinocytes. Exp. Dermatol. 17, 115-124 (2008).
77. Tsukada, J., Waterman, W. R., Koyama, Y., Webb, A. C. & Auron, P. E. A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a gamma interferon activation site-like element in the IL1B gene. Mol. Cell. Biol. 16, 2183-2194 (1996).
78. Kobierski, L. A., Srivastava, S. & Borsook, D. Systemic lipopolysaccharide and interleukin-1beta activate the interleukin 6: STAT intracellular signaling pathway in neurons of mouse trigeminal ganglion. Neurosci. Lett. 281, 61-64 (2000). (Pubitemid 30109305)
79. Youlyouz-Marfak, I. et al. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death Differ. 15, 376-385 (2008).
80. Warner, S. J., Auger, K. R. & Libby, P. Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells. J. Exp. Med. 165, 1316-1331 (1987). (Pubitemid 17073530)
81. Bellehumeur, C., Blanchet, J., Fontaine, J. Y., Bourcier, N. & Akoum, A. Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms. Hum. Reprod. 24, 2193-2204 (2009).
82. Pelegrin, P. & Surprenant, A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071-5082 (2006). (Pubitemid 44658525)
83. Boassa, D. et al. Pannexin1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J. Biol. Chem. 282, 31733-31743 (2007). (Pubitemid 350044851)
84. De Ridder, D. et al. Conservative bladder management in advanced multiple sclerosis. Mult. Scler. 11, 694-699 (2005). (Pubitemid 41685141)
85. Buttyan, R., Chen, M. W. & Levin, R. M. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction. Eur. Urol. 32 Suppl 1, 32-39 (1997). (Pubitemid 27280917)
86. Lyng, F. M. et al. Effect of a tobacco-related nitrosamine on intercellular communication in human urothelial cells: a possible factor in smoking-related bladder carcinogenesis. Oncol. Res. 8, 371-378 (1996). (Pubitemid 27016922)
87. Corteggio, A., Florio, J., Roperto, F.& Borzacchiello, G. Expression of gap junction protein connexin 43 in bovine urinary bladder tumours. J. Comp. Pathol. 144, 86-90 (2011).
88. Kanaporis, G., Brink, P. R. & Valiunas, V. Gap junction permeability: selectivity for anionic and cationic probes. Am. J. Physiol. Cell Physiol. 300, C600-C609 (2011).
89. Rubsamen, D. et al. IRES-dependent translation of egr2 is induced under inflammatory conditions. RNA 18, 1910-1920 (2012).
90. Schiavi, A., Hudder, A. & Werner, R. Connexin43 mRNA contains a functional internal ribosome entry site. FEBS Lett. 464, 118-122 (1999). (Pubitemid 30017926)
91. Ul-Hussain, M., Dermietzel, R. & Zoidl, G. Connexins and Cap-independent translation: role of internal ribosome entry sites. Brain Res. 1487, 99-106 (2012).
92. Stark, G. R. & Darnell, J. E. Jr. The JAK-STAT pathway at twenty. Immunity 36, 503-514 (2012).
93. Joshi, V. D. et al. A role for Stat1 in the regulation of lipopolysaccharide-induced interleukin-1beta expression. J. Interferon Cytokine Res. 26, 739-747 (2006). (Pubitemid 44934113)
94. Khazen, W. et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett. 579, 5631-5634 (2005). (Pubitemid 41455641)
95. Basu, A., Krady, J. K. & Levison, S. W. Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78, 151-156 (2004). (Pubitemid 39313786)